Studies show hydroxychloroquine kills the coronavirus, says Novartis CEO

Spinal Tech

Novartis CEO Vas Narasimhan said on March 29 that his company's hydroxychloroquine drug for malaria, lupus and arthritis is their biggest hope for tackling the coronavirus.

"Pre-clinical studies in animals as well as the first data from clinical studies show that hydroxychloroquine kills the coronavirus," Mr. Narasimhan said in an interview with Swiss newspaper SonntagsZeitung

Novartis is developing treatment protocols for clinical use of HCQ but Mr. Narasimhan said it's premature to definitely stand by the findings.

The company is donating 130 million doses of the drug and supporting clinical trials before the FDA approves HCQ to treat COVID-19.

Novartis is also studying three of its drugs for their effect on complications related to COVID-19.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Podcast

Featured Whitepapers